Company Filing History:
Years Active: 2010
Title: Yuval Reiss: Innovator in Ubiquitin Ligase Inhibitors
Introduction
Yuval Reiss is a notable inventor based in Kiriat-Ono, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit ubiquitin ligase activity. His work has implications for various medical applications, including antiviral and anticancer treatments.
Latest Patents
Yuval Reiss holds 1 patent for his invention titled "Ubiquitin ligase inhibitors and methods related thereto." This patent discloses compounds that inhibit ubiquitin ligase activity, which is crucial for regulating protein degradation in cells. The application also highlights the potential of these compounds in treating neurological disorders.
Career Highlights
Throughout his career, Yuval Reiss has worked with several companies, including Proteologies Ltd. and Proteologics Inc. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the biotechnology sector.
Collaborations
Yuval has collaborated with notable colleagues such as Iris Alroy and Shmuel Tuvia. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.
Conclusion
Yuval Reiss is a distinguished inventor whose work on ubiquitin ligase inhibitors has the potential to impact various therapeutic areas. His contributions to biotechnology continue to pave the way for innovative treatments and advancements in medical science.